Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a mindfulness program curb youth suicide? new study aims to find out

NCT ID NCT07395752

Symptom relief Sponsor: Ajou University School of Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a structured program called SHIELD to help young people aged 15-30 who have suicidal thoughts or self-harm. The program includes 8 weekly sessions tailored by age, focusing on stabilizing daily routines and emotions. Researchers will compare it to usual care and also look at brain scans to see if changes in mood are linked to brain activity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Self-Harm Intervention and Education for Long-term Development (SHIELD) Program
What this could lead to
If successful, this program could provide an effective, culturally tailored way to reduce suicidal thoughts and self-harm in young people.
What could go wrong
This is an early-stage study with only 100 participants, so results may not apply to everyone. The program is behavioral, so benefits depend on individual engagement and follow-through.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 30 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. General Criteria * Aged between 15 and 30 years * Obtained informed consent from a parent or legal guardian for participants under 19 years of age 2. For the Self-Harm Group * At least one incident of non-suicidal self-injury (NSSI) within the last 6 months * Self-Harm Screening Inventory (SHSI) score of at least 1 (at least one "Yes" response) 3. For the Suicide Attempt Group * Suicide attempt within the last 6 months * Depressive Symptom Inventory-Suicidality Subscale (DSI-SS) score of 3 or higher Exclusion Criteria: 1. Psychiatric and Developmental Conditions * History of developmental disorders, including intellectual disability or autism spectrum disorder * Diagnosis of schizophrenia or bipolar disorder * Currently in an acute psychotic state 2. Medical and Physical Conditions * Presence of severe physical illness that interferes with daily life * Presence of metallic substances in the body (e.g., cardiac pacemakers, artificial heart valves) that are incompatible with fMRI * Diagnosis of claustrophobia * Current Treatment and Intervention * Currently receiving regular and active cognitive behavioral therapy (CBT) * Initiation of pharmacological treatment within the last 2 months 3. Communication and Consent * Inability to communicate fluently in Korean * Failure to obtain informed consent from a parent or legal guardian for participants under 19 years of age

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Self-injurious behavior are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Self-Injurious Behavior Suicidal Ideation Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Self-injurious behavior Suicidal ideation Suicide, attempted

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ajou University Medical Center

    RECRUITING

    Suwon, Gyeonggi-do, 16499, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.